Double-Blind Randomised Investigation of Tibolone or Escitalopram in First Onset Perimenopausal Depression.

Trial Profile

Double-Blind Randomised Investigation of Tibolone or Escitalopram in First Onset Perimenopausal Depression.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 02 Sep 2014

At a glance

  • Drugs Tibolone (Primary) ; Escitalopram
  • Indications Depressive disorders; Menopausal syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Jul 2012 Planned number of patients changed from 240 to 45.
    • 10 Jul 2012 Planned end date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
    • 10 Jul 2012 Actual initiation date changed from Oct 2011 to Jul 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top